Azilsartan modulates HMGB1/NF-κB/p38/ERK1/2/JNK and apoptosis pathways during renal ischemia reperfusion injury
Renal ischemia/reperfusion (IR) injury is characterized by an unexpected impairment of
blood flow to the kidney. Azilsartan is an angiotensin receptor blocker that is approved for …
blood flow to the kidney. Azilsartan is an angiotensin receptor blocker that is approved for …
[PDF][PDF] Effects of Vinpocetine on Renal Ischemia Reperfusion Injury in a Male Rat Model.
WJ Abbas, ML Altemimi, RH Al-Mudhafar… - … Reviews in Pharmacy, 2020 - researchgate.net
Background: Ischemia-reperfusion injury (IRI) occurs when the blood supply to tissue
diminishes and subsequently restore. The basic pathophysiology involves reactive oxygen …
diminishes and subsequently restore. The basic pathophysiology involves reactive oxygen …
[PDF][PDF] Moexipril Improves Renal Ischemia/Reperfusion Injury in Adult Male Rats.
EH Alsaaty, AM Janabi - Journal of Contemporary Medical Sciences, 2024 - iasj.net
Objective: The goal of this study is to see if moexipril can protect rats against renal
ischemia/reperfusion injury. Methods: Overall twenty-eight males of rats were divided …
ischemia/reperfusion injury. Methods: Overall twenty-eight males of rats were divided …
The Anti-apoptotic, Anti-inflammatory and Antioxidant Effects of Ranolazine on Renal Ischemia Reperfusion Injury in Adult Male Rats.
LM ABBAS, AMA HAMEED… - International …, 2021 - search.ebscohost.com
Background: Renal ischemia and reperfusion is the main cause of acute injury of the kidney
and associated with increase morbidity, mortality, and long stage hospitalization. Renal …
and associated with increase morbidity, mortality, and long stage hospitalization. Renal …